Investment Summary |
|
|---|---|
| Date | 2022-10-04 |
| Target | Innovative ECMO Concepts |
| Sector | Education |
| Investor(s) | 1315 Capital |
| Deal Type | Growth Capital |
SEARCH BY
1315 Capital is a private investment firm that provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare service companies. The Firm will consider opportunities across the US and generally looks to commit $10 to $40 million per investment. 1315 Capital was formed in 2014 and is based in Philadelphia, Pennsylvania.
| DEAL STATS | # |
|---|---|
| Overall | 19 of 22 |
| Sector: Education M&A | 1 of 1 |
| Type: Growth Capital M&A Deals | 5 of 6 |
| State: Oklahoma M&A | 1 of 1 |
| Country: United States M&A | 17 of 20 |
| Year: 2022 M&A | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-07-13 |
Nutrisense
Chicago, Illinois, United States Nutrisense is a nutrition technology company helping its users improve their metabolic health through personalized data and dietitian support. Nutrisense was founded in 2019 and is based in Chicago, Illinois. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-11-02 |
Biocoat
Horsham, Pennsylvania, United States Biocoat develops and manufactures hydrophilic (lubricious) biomaterial coatings and related services for medical device manufacturers, offering coatings that are abrasion-resistant, biocompatible and designed to enhance device performance. The Company serves clients in the medical device industry through both product offerings and contract coating services. Biocoat was founded in 1991 and is headquartered in Horsham, Pennsylvania. |
Sell | - |
